Jiangxi Fushine Pharmaceutical Co., Ltd.
SZSE:300497.SZ
10.05 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 729.371 | 978.028 | 1,272.459 | 1,585.204 | 791.363 | 780.702 | 612.607 | 341.659 | 359.785 | 62.079 | 64.933 | 65.586 | 55.389 |
| Short Term Investments
| 2.185 | 49.742 | 150.758 | 106.676 | -8.686 | -3.721 | 0.114 | 170 | -0.481 | -0.662 | 0.013 | -0.185 | 0.096 |
| Cash and Short Term Investments
| 731.556 | 1,027.769 | 1,423.217 | 1,691.88 | 791.363 | 780.702 | 612.721 | 341.659 | 359.785 | 62.079 | 64.946 | 65.586 | 55.486 |
| Net Receivables
| 624.542 | 570.209 | 400.25 | 342.971 | 314.892 | 242.548 | 196.85 | 175.609 | 159.956 | 140.531 | 98.583 | 100.604 | 66.71 |
| Inventory
| 434.678 | 553.69 | 416.148 | 287.984 | 235.64 | 212.024 | 186.093 | 168.125 | 110.718 | 116.582 | 80.824 | 61.791 | 64.947 |
| Other Current Assets
| 86.663 | 77.61 | 71.94 | 43.829 | 48.15 | 13.99 | 10.249 | 175.184 | -2.934 | -15.99 | 0.638 | 3.819 | -3.201 |
| Total Current Assets
| 1,877.439 | 2,229.278 | 2,311.556 | 2,366.664 | 1,390.045 | 1,249.264 | 1,005.913 | 860.577 | 627.525 | 303.202 | 244.991 | 231.8 | 183.941 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 2,330.765 | 2,201.002 | 1,857.016 | 1,198.529 | 904.193 | 662.754 | 508.105 | 422.68 | 303.134 | 252.908 | 219.131 | 166.929 | 95.676 |
| Goodwill
| 0 | 1.147 | 2.218 | 2.218 | 2.218 | 2.218 | 4.992 | 2.218 | 1.147 | 1.147 | 1.147 | 1.147 | 0 |
| Intangible Assets
| 241.066 | 249.708 | 256.318 | 246.276 | 116.509 | 102.581 | 107.755 | 83.805 | 60.848 | 61.873 | 63.27 | 64.62 | 61.673 |
| Goodwill and Intangible Assets
| 241.066 | 250.854 | 258.536 | 248.493 | 118.727 | 104.799 | 112.746 | 86.022 | 61.994 | 63.02 | 64.417 | 65.766 | 61.673 |
| Long Term Investments
| 269.086 | 221.677 | -17.738 | 47.103 | 147.564 | 141.229 | 143.846 | 14.87 | 10.441 | 10.622 | 9.947 | 10.145 | 9.864 |
| Tax Assets
| 29.37 | 28.491 | 27.541 | 9.294 | 5.899 | 4.636 | 5.24 | 11.142 | 2.395 | 1.312 | 1.173 | 1.097 | 1.319 |
| Other Non-Current Assets
| 71.313 | 128.532 | 241.581 | 175.583 | 29.373 | 33.802 | 13.559 | 3.076 | 4.169 | 1.285 | 1.649 | 0.571 | 0.096 |
| Total Non-Current Assets
| 2,941.6 | 2,830.556 | 2,366.935 | 1,679.002 | 1,205.755 | 947.22 | 783.495 | 537.79 | 382.133 | 329.146 | 296.317 | 244.509 | 168.628 |
| Total Assets
| 4,819.039 | 5,059.834 | 4,678.491 | 4,045.666 | 2,595.8 | 2,196.484 | 1,789.408 | 1,398.367 | 1,009.659 | 632.348 | 541.308 | 476.308 | 352.568 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 581.934 | 656.667 | 517.05 | 418.6 | 241.303 | 226.903 | 211.942 | 172.921 | 117.921 | 122.711 | 117.939 | 126.822 | 89.783 |
| Short Term Debt
| 628.606 | 374.693 | 648.678 | 377.383 | 408.926 | 639.59 | 339.64 | 217 | 162.84 | 133 | 86.09 | 104.74 | 83.499 |
| Tax Payables
| 7.626 | 17.283 | 19.616 | 47.89 | 40.353 | 31.842 | 12.454 | 16.921 | 7.68 | 4.695 | 4.534 | 2.076 | 3.101 |
| Deferred Revenue
| 49.95 | 193.35 | 154.603 | 88.071 | 70.472 | 58.096 | 43.412 | 62.908 | 20.985 | 18.503 | 14.68 | 12.719 | 10.697 |
| Other Current Liabilities
| 25.107 | 34.147 | 39.631 | 0.85 | 4.575 | 37.426 | 80.99 | 53.068 | 0.039 | 2.199 | 0.906 | 0.883 | 0.74 |
| Total Current Liabilities
| 1,285.597 | 1,258.857 | 1,359.961 | 884.904 | 725.276 | 962.015 | 675.984 | 505.897 | 301.785 | 276.413 | 219.615 | 245.163 | 184.72 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 998.264 | 1,043.044 | 353 | 65 | 294.308 | 37 | 93 | 61.786 | 65.36 | 26 | 46 | 0 | 0 |
| Deferred Revenue Non-Current
| 62.385 | 62.027 | 50.302 | 43.728 | 44.012 | 44.734 | 45.456 | 45.578 | 46.3 | 46.26 | 45.931 | 46.541 | 0 |
| Deferred Tax Liabilities Non-Current
| 2.053 | 6.27 | 3.92 | 4.295 | 4.699 | 6.047 | 8.261 | 0.935 | -65.36 | 0 | 0.002 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 65.36 | 0.413 | 0 | 0 | 47.324 |
| Total Non-Current Liabilities
| 1,062.702 | 1,111.341 | 407.223 | 113.024 | 343.02 | 87.782 | 146.717 | 108.299 | 111.66 | 72.673 | 91.933 | 46.541 | 47.324 |
| Total Liabilities
| 2,348.299 | 2,370.198 | 1,767.184 | 997.927 | 1,068.296 | 1,049.797 | 822.701 | 614.197 | 413.445 | 349.085 | 311.548 | 291.704 | 232.044 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39.872 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 550.005 | 550.005 | 550.005 | 550.005 | 273.272 | 224.621 | 112.31 | 112.037 | 72 | 54 | 54 | 54 | 16 |
| Retained Earnings
| 536.616 | 737.417 | 878.888 | 948.584 | 717.263 | 528.37 | 408.051 | 302.682 | 181.704 | 118.824 | 71.034 | 30.077 | 96.524 |
| Accumulated Other Comprehensive Income/Loss
| 14.297 | 169.207 | 51.845 | 44.06 | 105.645 | 369.825 | 28.206 | -39.872 | 24.278 | 0.145 | 0.084 | 0 | 0 |
| Other Total Stockholders Equity
| 1,383.88 | 1,224.611 | 1,399.469 | 1,464.697 | 393.81 | -6.599 | 388.307 | 341.299 | 318.232 | 110.294 | 104.642 | 100.527 | 8 |
| Total Shareholders Equity
| 2,484.799 | 2,681.239 | 2,880.207 | 3,007.346 | 1,489.989 | 1,116.217 | 936.874 | 756.018 | 596.214 | 283.263 | 229.76 | 184.604 | 120.524 |
| Total Equity
| 2,470.74 | 2,689.636 | 2,911.307 | 3,047.739 | 1,527.504 | 1,146.687 | 966.706 | 784.17 | 596.214 | 283.263 | 229.76 | 184.604 | 120.524 |
| Total Liabilities & Shareholders Equity
| 4,819.039 | 5,059.834 | 4,678.491 | 4,045.666 | 2,595.8 | 2,196.484 | 1,789.408 | 1,398.367 | 1,009.659 | 632.348 | 541.308 | 476.308 | 352.568 |